The targeting construct is composed of an FRT site, EGFP, a loxP site, a neomycin cassette, and an FRT site upstream of exon 2. A second loxP is inserted site downstream of exon 2. Flp-mediated recombination removed the FRT-flanked EGFP and neo cassette leaving exon 2 floxed. Cre-mediated recombination removed exon 2. Immunoblot analysis confirms the absence of protein in the hippocampus. (J:263547)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count